- Investing Ideas
- /
- South Korean Pharmaceuticals & Biotech Undervalued based on future growth
South Korean Pharmaceuticals & Biotech Undervalued based on future growth
Results
4
0 new
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
4 companies
Dong-A Socio Holdings
Market Cap: ₩769.7b
Engages in the pharmaceutical business in South Korea.
A000640
₩119,600.00
7D
5.0%
1Y
13.1%
DongKook Pharmaceutical
Market Cap: ₩769.3b
Produces and sell pharmaceutical products in South Korea and internationally.
A086450
₩17,330.00
7D
0.5%
1Y
-5.6%
Boryung
Market Cap: ₩714.5b
Engages in the manufacture and sale of pharmaceutical products in South Korea and internationally.
A003850
₩8,510.00
7D
-1.6%
1Y
-17.1%
JW Pharmaceutical
Market Cap: ₩542.8b
Manufactures and sells medicines and medical supplies in Japan and internationally.
A001060
₩23,400.00
7D
1.5%
1Y
-17.9%